119 related articles for article (PubMed ID: 6829493)
1. A phase II study of alanosine in advanced large bowel carcinoma.
Rubin J; Hineman V; Moertel CG; Schutt AJ; Hahn RG
Am J Clin Oncol; 1983 Apr; 6(2):191-3. PubMed ID: 6829493
[TBL] [Abstract][Full Text] [Related]
2. Clinical trial of PALA and L-Alanosine in advanced colorectal carcinoma.
O'Connell MJ; Rubin J; Schutt AJ; Moertel CG; Kvols LK
Cancer Treat Rep; 1983 Dec; 67(12):1141-2. PubMed ID: 6360350
[No Abstract] [Full Text] [Related]
3. Phase I study of L-alanosine (NSC 15353).
Goldsmith MA; Ohnuma T; Spigelman M; Greenspan EM; Holland JF
Cancer; 1983 Feb; 51(3):378-80. PubMed ID: 6821823
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
Rubin J; Kvols LK; Moertel CG; Jones AR; Hahn RG; O'Connell MJ
Am J Clin Oncol; 1983 Aug; 6(4):477-9. PubMed ID: 6869319
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of L-alanosine (NSC 153353) in patients with advanced breast cancer. A Southwest Oncology Group study.
Von Hoff DD; Green SJ; Neidhart JA; Fabian C; Budd T; Boyd JF; Osborne CK
Invest New Drugs; 1991 Feb; 9(1):87-8. PubMed ID: 2026487
[No Abstract] [Full Text] [Related]
6. Phase II evaluation of pyrazofurin in patients with advanced colorectal carcinoma.
Carroll DS; Kemeny NE; Gralla RJ
Cancer Treat Rep; 1979 Jan; 63(1):139-40. PubMed ID: 369686
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of L-alanosine (NSC-153353) for patients with disseminated malignant melanoma.
Creagan ET; Long HJ; Ahmann DL; Green SJ
Am J Clin Oncol; 1984 Oct; 7(5):543-4. PubMed ID: 6507375
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer.
Rubin J; Schutt AJ; O'Connell MJ; Gertz MA; Moertel CG
Am J Clin Oncol; 1984 Oct; 7(5):523-5. PubMed ID: 6507373
[TBL] [Abstract][Full Text] [Related]
11. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of pyrazofurin in advanced colorectal carcinoma.
Creagan ET; Rubin J; Moertel CG; Schutt AJ; O'connell MJ; Hahn RG; Reitemeir RJ; Frytak S
Cancer Treat Rep; 1977; 61(3):491-3. PubMed ID: 872147
[No Abstract] [Full Text] [Related]
13. A phase II study of triazinate (NSC 139105) in advanced colorectal carcinoma.
McCreary RH; Moertel CG; Schutt AJ; O'Connell MJ; Hahn RG; Reitemeier RJ; Rubin J; Frytak S
Cancer; 1977 Jul; 40(1):9-13. PubMed ID: 141977
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
Ferrazzi E; Pappagallo GL; Nicoletto O; Fornasiero A; Refatti F; Cartei G; Vinante O; Fiorentino MV
Tumori; 1984 Jun; 70(3):297-300. PubMed ID: 6588671
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
Wils JA
Invest New Drugs; 1984; 2(4):397-9. PubMed ID: 6595243
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
Fiore J; Kemeny N; Raymond V; Young C
Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
[No Abstract] [Full Text] [Related]
17. A phase II study of chlorozotocin in advanced large bowel carcinoma. A cooperative study between two institutions.
Schutt AJ; Hoth D; Moertel CG; Schein PS; Rubin J; O'Connell MJ
Am J Clin Oncol; 1984 Oct; 7(5):507-11. PubMed ID: 6239538
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of 3-deazauridine in advanced colorectal adenocarcinoma.
Bruno S; Creaven PJ; Ledesma E; Poster D; Yoon J; Mittelman A
Am J Clin Oncol; 1982 Feb; 5(1):69-71. PubMed ID: 7081140
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma.
Rubin J; Sorensen S; Schutt AJ; van Hazel GA; O'Connell MJ; Moertel CG
Am J Clin Oncol; 1983 Jun; 6(3):325-6. PubMed ID: 6846250
[No Abstract] [Full Text] [Related]
20. The treatment of acute leukemia with continuous infusion L-Alanosine.
Weick JK; Tranum BL; Morrison FS
Invest New Drugs; 1983; 1(3):249-51. PubMed ID: 6678874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
